PKC412

Name: PKC412
SKU: P4008
Availability: InStock

Product ID P4008

Cas No. 120685-11-2

Purity ≥98%

Product Unit Size	Cost	Quantity		Stock

Bulk Quote

Quicklinks

Description
Product Info
Shipping and Storage
Downloads
References

Description

PKC412 is an anti-metastatic and anticancer chemotherapeutic staurosporine derivative that inhibits FMS-like tyrosine kinase 3 (FLT3) and is currently in clinical trials as a potential treatment for acute myelogenous leukemia (AML). PKC412 also inhibits PKC. In keloid-derived fibroblasts, PKC412 increases activity of caspase 3, inducing apoptosis. In animal models of melanoma, PKC412 inhibits metastasis and platelet-aggregating activity. This compound also alters differentiation patterns of dendritic cells ex vivo.

Product Info

Cas No.	120685-11-2
Purity	≥98%
Formula	C₃₅H₃₀N₄O₄
Formula Wt.	570.64
Synonym	Midostaurin, 4'-N-Benzoyl staurosporine
Melting Point	235-260°C
Solubility	DMSO, Dichloromethanol
Appearance	Off white powder

Shipping and Storage

Store Temp	4°C
Ship Temp	Ambient

Downloads

MSDS	P4008 MSDS PDF
Info Sheet	P4008 Info Sheet PDF

References

Fischer T, Stone RM, Deangelo DJ, et al. Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3. J Clin Oncol. 2010 Oct 1;28(28):4339-45. PMID: 20733134.

Huang YC, Shieh HR, Chen YJ. Midostaurin (PKC412) modulates differentiation and maturation of human myeloid dendritic cells. Toxicol In Vitro. 2010 Sep;24(6):1705-10. PMID: 20685248.

Stölzel F, Steudel C, Oelschlägel U, et al. Mechanisms of resistance against PKC412 in resistant FLT3-ITD positive human acute myeloid leukemia cells. Ann Hematol. 2010 Jul;89(7):653-62. PMID: 20119833.

Nakazono-Kusaba A, Takahashi-Yanaga F, Miwa Y, et al. PKC412 induces apoptosis through a caspase-dependent mechanism in human keloid-derived fibroblasts. Eur J Pharmacol. 2004 Aug 23;497(2):155-60. PMID: 15306200.

Yoshikawa N, Nakamura K, Yamaguchi Y, et al. Effect of PKC412, a selective inhibitor of protein kinase C, on lung metastasis in mice injected with B16 melanoma cells. Life Sci. 2003 Feb 7;72(12):1377-87. PMID: 12527035.

Custom Order

Name*
First Last
Company/Institution
Email*
Enter Email Confirm Email
Product ID
Product Name
Unit Size
Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
Unit Label
Quantity
Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
Comments
Name
This field is for validation purposes and should be left unchanged.

PKC412

Quicklinks

Description

Product Info

Shipping and Storage

Downloads

References

Custom Order

Related Products

Thalidomide

Pyr-GR-pNA

Pentoxifylline

(Z)-4-Hydroxytamoxifen

Bradykinin (2-9)

2-Deoxy-D-glucose

2’-TBS-Cabazitaxel

Deboc-Cabazitaxel

Budesonide

2’-TES-Cabazitaxel

Gonadorelin Acetate

Pituitary Adenylate Cyclase-activating Polypeptide-related Peptide, rat

Stavudine

Piperine

2’-THP-Cabazitaxel

Levosimendan

N-Cinnamoyl-N-debenzoyl Paclitaxel

Ursodeoxycholic Acid

n-Butyric Acid

Neomycin Sulfate

Footer